中文速读
针对KRAS G12V突变驱动的结直肠癌,使用SW620细胞皮下移植瘤裸鼠模型,通过Entranster-in vivo体内转染Pistol17及capped-Pistol17核酶,抑制肿瘤生长,capped-Pistol17组肿瘤抑制率达85%以上。
小鼠瘤内肿瘤SW620
Engineered pistol ribozymes selectively target KRAS G12V with enhanced efficacy by capping modification
Affiliations
- 1 State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China; China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China.
- 2 State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China.
- 3 School of Medicine, University of St Andrews, North Haugh, St Andrews, Fife KY16 9TF, UK.
- 4 China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China.
- 5 China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China. Electronic address: yili.yang@icgeb.cn.
- 6 State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China. Electronic address: yvliu@nankai.edu.cn.
- PMID: 41864209
- DOI: 10.1016/j.chembiol.2026.03.001
Abstract
In this study, we rationally engineered a previously characterized pistol ribozyme to selectively target the KRAS p.G12V mutation with high specificity and efficiency. The pseudoknot-induced compact folding structure of the pistol ribozyme provides three-dimensional structural recognition of the KRAS substrate, distinguishing it from siRNA and ASO, which rely solely on primary sequence complementarity. This structural advantage enables the designed pistol ribozyme to effectively differentiate between KRAS wild-type and G12V mutant RNA. Furthermore, compared with 3′ end nucleotide derivative modifications, 5′ end capping is more effective at increasing ribozyme stability and compatibility with in vitro preparations. These features underscore the promising potential of natural pistol ribozymes as advanced therapeutic nucleic acid molecules for targeting KRAS mutation-driven cancers and suggest a generalizable strategy for structure-guided, allele-specific RNA therapeutics.
Keywords: KRAS mutation; catalysis; gene therapy; modification; pistol ribozyme.
RNA体内转染Entranster™-in vivo 已有 503 篇已发表文献
同类研究
- Sci Adv. 2026 Oct 28;12(44):eaee0110.doi: 10.1126/sciadv.aee0110. An oxidized ribonucleotide 8-oxoGTP drives neuroinflam…
- Bioact Mater. 2026 Jul 12;66:487-507.doi: 10.1016/j.bioactmat.2026.06.047. Targeting ROAM1 with UDP-GlcNAc nanosheets se…
- Transl Psychiatry. 2026 Jul 1.doi: 10.1038/s41398-026-04221-0. Natural flavonoid dihydroquercetin blocks Trim14-JAK1-STA…
- Front Cell Dev Biol. 2026 Jun 17:14:1677758.doi: 10.3389/fcell.2026.1677758. Rare variants of GPSM2 associated with aneu…
- Front Cell Dev Biol. 2026 May 20;14:1771279.doi: 10.3389/fcell.2026.1771279. Dermal mesenchymal stem cells promote angio…